Trinity Biotech plc announced that it has achieved Adjusted EBITDA-positive operations during Q2 2025 and expects to maintain this positive trajectory going forward, marking a key milestone in its ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results